Tag:
siRNA
Latest Headlines
Latest Headlines
UNC researchers craft siRNA platform that can switch its solubility
Scientists at UNC have come up with a drug carrier that holds together in the blood stream and then dissolves once it reaches its target cells.
Ensysce says carbon nanotubes delivered cancer drug
Ensysce Biosciences says early in vivo experiments using single-walled carbon nanotubes to deliver siRNA drugs to cancer tumors have been so promising, the company will proceed to human clinical
UPDATED: Alnylam throws legal punch in patent fight with RNAi tech partner Tekmira
This is growing nastier. Alnylam Pharmaceuticals ( $ALNY ) has fired the latest round—this time in federal court—in an ongoing patent feud with development partner Tekmira Pharmaceuticals (...
SPANosomes deliver siRNA more effectively
If not for a delivery problem, gene-silencing siRNA therapy would be much closer to reality inside the clinic today. But more than a decade after its discovery, siRNA has proven to be difficult to
Alnylam, MIT team up for 'binary' approach to delivering siRNA
Gene-silencing siRNA technology has failed to live up to its original hype largely because of problems delivering short interfering RNA to the precise spot where it's needed. Alnylam Pharmaceuticals,
Carbon nanotubes deliver siRNA in post-stroke treatment
Those who follow research into nanotech-enabled drug delivery would be interested in a recent in-vivo test by European scientists of delivery of gene silencing siRNA via carbon nanotubes. The
Brain tumor starved of iron, making chemo more effective
The blood-brain barrier prevents effective treatment of malignant glioblastoma multiforme, which is one reason why this form of brain tumor is so deadly. Increasing the dosage is not an option, since
Packaging RNA for long-lasting, nontoxic delivery
Use of RNA for drug delivery has alternatively inspired and frustrated researchers for years. It seems like a perfect tool to deliver therapeutics to targeted cells. The frustrating part is that it
Texas researchers find a better way of delivering siRNA
While some drug companies have thrown up their hands in frustration at the challenges in delivering small interfering RNA (siRNA), or gene-silencing particles that could figuratively shut up cancer,
Researchers develop oral delivery of siRNA
We have reported many times on both the promise and the problems associated small interfering RNA (siRNA). They can "silence" genes that cause specific diseases. That’s the promise. The
